Asia Pacific Immunotech Venture Limited - Net Worth and Insider Trading

Asia Pacific Immunotech Venture Limited Net Worth

The estimated net worth of Asia Pacific Immunotech Venture Limited is at least $924 Million dollars as of 2024-04-28. Asia Pacific Immunotech Venture Limited is the of Mabpharm Ltd and owns about 2,227,000,000 shares of Mabpharm Ltd (HKSE:02181) stock worth over $924 Million. Details can be seen in Asia Pacific Immunotech Venture Limited's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Asia Pacific Immunotech Venture Limited has not made any transactions after 2019-05-31 and currently still holds the listed stock(s).

Transaction Summary of Asia Pacific Immunotech Venture Limited

Asia Pacific Immunotech Venture Limited Latest Holdings Summary

Asia Pacific Immunotech Venture Limited currently owns a total of 1 stock. Asia Pacific Immunotech Venture Limited owns 2,227,000,000 shares of Mabpharm Ltd (HKSE:02181) as of May 31, 2019, with a value of $924 Million.

Latest Holdings of Asia Pacific Immunotech Venture Limited

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:02181	Mabpharm Ltd	2019-05-31	2,227,000,000	0.42	924,205,000

Holding Weightings of Asia Pacific Immunotech Venture Limited

Asia Pacific Immunotech Venture Limited Form 4 Trading Tracker

According to the SEC Form 4 filings, Asia Pacific Immunotech Venture Limited has made a total of 1 transactions in Mabpharm Ltd (HKSE:02181) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Mabpharm Ltd is the sale of 0 shares on May 31, 2019, which brought Asia Pacific Immunotech Venture Limited around $0.

Insider Trading History of Asia Pacific Immunotech Venture Limited

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Asia Pacific Immunotech Venture Limited Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Asia Pacific Immunotech Venture Limited Ownership Network

Ownership Network List of Asia Pacific Immunotech Venture Limited

No Data

Ownership Network Relation of Asia Pacific Immunotech Venture Limited

Asia Pacific Immunotech Venture Limited Mailing Address

Above is the net worth, insider trading, and ownership report for Asia Pacific Immunotech Venture Limited. Currently GuruFocus does not have mailing address information for Asia Pacific Immunotech Venture Limited.

Discussions on Asia Pacific Immunotech Venture Limited

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.